Phase 3 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have given written consent after being fully informed about the trial.
- People aged 18 years or older.
- People with a confirmed diagnosis of Extensive Stage Small Cell Lung Cancer (ES-SCLC), which means the cancer has spread beyond one lung.
- People with a good general health and activity level, able to carry out normal daily activities with little or no limitation (confirm with trial site what this score means for a specific situation).
- People who have not had any previous systemic (whole-body) cancer treatment, except for an initial course of immunotherapy combined with chemotherapy for ES-SCLC.
- People whose cancer showed a partial response or remained stable after 4 to 6 cycles of that initial treatment combining an immune checkpoint drug with platinum-based chemotherapy and etoposide, with the last tumour assessment done no more than 28 days before joining the trial.
- People assessed by a radiation specialist as suitable to receive radiotherapy to the chest, based on safe dose limits for the surrounding lung tissue.
- People who have cancer that has spread to the brain but whose brain metastases are stable and not causing symptoms.
- People with adequately functioning bone marrow, kidneys, and liver.
- People of childbearing potential who are willing to use effective contraception throughout the study and for 6 months after the last dose of the study drug.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received radiotherapy to the chest.
- People with a history of certain lung conditions, such as pulmonary fibrosis, or any form of lung inflammation (pneumonitis), including drug-related or unexplained causes, or who show signs of active lung inflammation on a chest scan at screening.
- People who test positive for hepatitis B surface antigen, hepatitis C virus RNA, or HIV.
- People whose cancer has spread to the membranes surrounding the brain and spinal cord (leptomeningeal metastasis).
- People with cancer-related pain that is not well controlled.
- People with uncontrolled fluid build-up around the lungs, heart, or abdomen that requires drainage procedures once a month or more often.
- People who have had another cancer (other than non-small cell lung cancer) within the past 5 years, unless that cancer was treated with an expected curative outcome.
- People with an active autoimmune disease, a history of autoimmune disease, or a condition that weakens the immune system.
- People with significant heart or blood vessel problems, such as a moderate-to-severe heart condition, a heart attack or stroke within the past 3 months, or unstable heart rhythm or chest pain.
- People who have had a major surgical procedure (not including surgery only for diagnosis) within 4 weeks before joining, or who are expected to need major surgery during the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8601088196087
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.